参考文献/References:
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. A Cancer Journal for Clinicians, 2018, 68(6): 394-424.
[2] 张宇,陈华国,赵超,等. 中药有效成分抗肝癌作用机制研究进展[J]. 中国中药杂志,2020,45(14): 3395-3406.
[3] Liao X., Bu Y, Jia Q. Traditional Chinese medicine as supportive care for the management of liver cancer: past, present, and future[J]. Genes and Diseases, 2020,7(3): 370-379.
[4] 周静,付先芸,蔡三金,等. 竹节参的化学成分、药理作用及质量标志物(Q-Marker)预测分析[J]. 中草药, 2021,52(9): 2819-2830.
[5] 陈颖,周岩,曹银萍. 中药皂苷类化合物体外抗肿瘤研究进展[J]. 中国医院药学杂志,2011,31(7): 591-593.
[6] Jiang N, Dai Q, Su X, et al. Role of PI3K/AKT pathway in cancer: the framework of malignant behavior[J]. Molecular Biology Reports, 2020, 47(6): 4587-4629.
[7] Lin J, Cao S, Wang Y, et al. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1alpha/ VEGFA signalling in hepatocellular carcinoma[J]. Journal of Experimental and Clinical Cancer Research, 2018, 37(1): 113.
[8] Pan W, Li W, Zhao J, et al. lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/ AKT/Caspase 3 pathway[J]. Molecular Oncology, 2019, 13(10): 2246-2258.
[9] Mizerska-Dudka M, Kandefer-Szerszen M. Opioids, neutral endopeptidase, its inhibitors and cancer: is there a relationship among them?[J]. Archivum Immunologiae et Therapiae Experimentalis, 2015, 63(3):197-205.
[10] Rascio F, Spadaccino F, Rocchetti, M T, et al. The pathogenic role of PI3K/AKT pathway in cancer onset and Drug resistance: an updated review[J]. Cancers, 2021, 13(16): 3949.
[11] Goodson W H, Lowe L, Carpenter D O, et al. Assessing the carcinogenic potential of low-doseexposures to chemical mixtures in the environment: the challenge ahead[J]. Carcinogenesis, 2015, 36(Suppl 1): S254-S296.
[12] Yang Y M, Kim S Y, Seki E. Inflammation and liver cancer: molecular mechanisms and therapeutic targets[J]. Seminars in Liver Disease, 2019, 39(1): 26-42.
[13] He G, Karin M. NF-κB and STAT3-key players in liver inflammation and cancer[J]. Cell Research, 2011, 21(1): 159-168.
相似文献/References:
[1]李鹏程 韦艾凌 张永琴 唐秋媛.中医药调控肝癌血管生成的研究近况[J].大众科技,2014,16(11):136.
Research status on traditional Chinese medicine of angiogenesis inhepatocellular carcinoma[J].Popular Science & Technology,2014,16(02):136.
[2]张荣臻.,陈楚寒,易鑫宇,等.中西医结合防治肝癌切除术后的研究进展[J].大众科技,2019,21(05):75.
Research of Integrated Chinese and Western Medicine in the Prevention andTreatment of Hepatocellular Carcinoma after Hepatectomy[J].Popular Science & Technology,2019,21(02):75.
[3]王新雨,李丽娟,何国珍,等.Sonic Hedgehog 信号通路与胚胎发育和肝癌发生[J].大众科技,2019,21(06):97.
Sonic Hedgehog Signaling Pathway in Embryonic Development and Liver Cancer[J].Popular Science & Technology,2019,21(02):97.